Melanoma molecular subtypes: unifying and paradoxical results
- PMID: 20010862
- PMCID: PMC2950747
- DOI: 10.1038/jid.2009.332
Melanoma molecular subtypes: unifying and paradoxical results
Abstract
In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating strong associations.
Conflict of interest statement
The authors state no conflict of interest.
Figures
Comment on
-
The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.J Invest Dermatol. 2010 Jan;130(1):241-8. doi: 10.1038/jid.2009.182. J Invest Dermatol. 2010. PMID: 19571821
References
-
- Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R. The melanocortin 1 receptor and the UV response of human melanocytes--a shift in paradigm. Photochem Photobiol. 2008;84:501–508. - PubMed
-
- Beaumont KA, Shekar SN, Cook AL, Duffy DL, Sturm RA. Red hair is the null phenotype of MC1R. Hum Mutat. 2008;29:E88–E94. - PubMed
-
- Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–2147. - PubMed
-
- Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet. 2004;13:447–461. - PubMed
-
- Edlundh-Rose E, Egyhazi S, Omholt K, Mansson-Brahme E, Platz A, Hansson J, et al. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 2006;16:471–478. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
